Filter posts

Biotech IP Challenges Around the World: BIO’s Special 301 Submission

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  …

Patent Awards for Humanitarian Ventures

The USPTO recently announced the Patents for Humanity Challenge which awards patent owners and licensees …

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Editor’s Note: Despite the progress in polio and other diseases made possible by vaccines, today …

Brazilian Innovation: A Patent Success

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  …

NIH Licensing Efforts Target Start-Ups

The National Institutes of Health (NIH) has developed a new short-term licensing arrangement they hope …

Exclusive Licenses Do Not Discourage Follow On Research

A recent study presented at the Patent Statistics for Decision Makers Conference organized at the …

BIO's Prometheus v. Mayo Amicus Brief Filed

BIO filed an amicus brief in the Prometheus v. Mayo Clinic case.  In this case …

EU Stem Cell Patent Decision Hurts Science

A great article in the Economist titled European science stemmed addresses the recent and controversial decision …

Australian Senate Committee Recommends Against Banning 'Gene Patents'

The Australian Senate Legal and Constitutional Affairs Legislation Committee recommended against the Patent Amendment (Human …

Technology Transfer Symposium in San Francisco

In the midst of turbulent economic times, and at a moment when the U.S. is …